Your browser doesn't support javascript.
loading
Impact of Medication Adherence on Virologic Failure in A5202: A Randomized, Partially Blinded, Phase 3B Study.
Parker, Robert A; Rabideau, Dustin J; Sax, Paul E; Tierney, Camlin; Daar, Eric S; Collier, Ann C; Losina, Elena; Freedberg, Kenneth A.
Afiliação
  • Parker RA; Biostatistics Center, and.
  • Rabideau DJ; Medical Practice Evaluation Center, Massachusetts General Hospital.
  • Sax PE; Harvard Medical School.
  • Tierney C; Harvard University Center for AIDS Research.
  • Daar ES; Biostatistics Center, and.
  • Collier AC; Harvard Medical School.
  • Losina E; Division of Infectious Diseases, Brigham and Women's Hospital, and.
  • Freedberg KA; Center for Biostatistics in AIDS Research in the Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Clin Infect Dis ; 64(11): 1612-1614, 2017 Jun 01.
Article em En | MEDLINE | ID: mdl-28329243
ABSTRACT
In AIDS Clinical Trials Group A5202, participants who reported missing their medication within the past month or not providing adherence reports at both 8 and 24 weeks had 5 times the hazard of virological failure compared to more adherent participants. Adherence interventions should focus on such patients.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / Fármacos Anti-HIV / Adesão à Medicação Tipo de estudo: Clinical_trials Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / Fármacos Anti-HIV / Adesão à Medicação Tipo de estudo: Clinical_trials Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2017 Tipo de documento: Article